1. Home
  2. PDLB vs STRO Comparison

PDLB vs STRO Comparison

Compare PDLB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

N/A

Current Price

$16.45

Market Cap

405.9M

Sector

N/A

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$25.20

Market Cap

85.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PDLB
STRO
Founded
1960
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
405.9M
85.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PDLB
STRO
Price
$16.45
$25.20
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$18.88
AVG Volume (30 Days)
64.4K
139.7K
Earning Date
04-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
206.67
N/A
EPS
0.77
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$63.08
Revenue Next Year
N/A
N/A
P/E Ratio
$21.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.88
$0.52
52 Week High
$18.01
$25.68

Technical Indicators

Market Signals
Indicator
PDLB
STRO
Relative Strength Index (RSI) 45.21 77.95
Support Level $15.83 $0.76
Resistance Level $17.29 N/A
Average True Range (ATR) 0.40 2.05
MACD -0.03 0.46
Stochastic Oscillator 38.53 92.12

Price Performance

Historical Comparison
PDLB
STRO

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: